Skip to content

Psychedelic therapies continue to be seen as big trend in MH treatment

Valerie A. Canady

Mental Health Weekly January 17, 2022 DOI: 10.1002/mhw.33073 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed
Topics Psychedelic-assisted therapy
Key points The text states that research is revealing that psychedelics show promise as treatments for depression and PTSD, and that psychedelic therapies continue to be studied in clinical trials around the country. No specific results, effect sizes, or trial details are provided.

Abstract

Research is revealing that psychedelics are showing promise as mental health treatment for depression and post‐traumatic stress disorder (PTSD). Psychedelic therapies continue to be studied in clinical trials around the country.

Explore topics